Six-Month Incidence, Clearance and Persistence of Oral High Risk HPV Infection...
28th International Papillomavirus Conference held at San Juan, Puerto Rico
Plenary Session 3 - HPV and Head and Neck Cancers
Presentation: Six-Month Incidence, Clearance and Persistence of Oral High Risk HPV Infection in HIV-Negative And HIV-Infected Men Who Have Sex with Men
Presenter: Sofie Mooij
Plenary Chairs: Maura Gillison and Xavier Castellsagué
December 5, 2012
Видео Six-Month Incidence, Clearance and Persistence of Oral High Risk HPV Infection... канала HPV2012PuertoRico
Plenary Session 3 - HPV and Head and Neck Cancers
Presentation: Six-Month Incidence, Clearance and Persistence of Oral High Risk HPV Infection in HIV-Negative And HIV-Infected Men Who Have Sex with Men
Presenter: Sofie Mooij
Plenary Chairs: Maura Gillison and Xavier Castellsagué
December 5, 2012
Видео Six-Month Incidence, Clearance and Persistence of Oral High Risk HPV Infection... канала HPV2012PuertoRico
Комментарии отсутствуют
Информация о видео
7 мая 2013 г. 16:48:47
00:13:14
Другие видео канала
Control of Radiation Response by P53 in Human Papillomavirus Positive Head and Neck Cancer
Management of HPV+/cyto- and ASC-US/HPV in Women By Phil Castle
Cervical Pre-Cancer and Cancer Rates After Primary HPV Test Versus Primary Cytology...
Differences in Oral and Anal HPV Natural History Among HIV-Infected Individuals by Daniel Beachler
HPV and HIV by Patti Gravitt
WHO Guidelines on Cervical Cancer Screening by Nathalie Broutet
Therapeutic Vaccines: Knowns, Unknowns by Margaret Stanley
Molecular Classification of Cervical Intraepithelial Neoplasia and Carcinoma by Luisa Escobar-Hoyos
The Papillomavirus Episteme (PAVE) by Koenraad Van Doorslaer
Virus Host Interaction at the Squamocolumnar Junction by Magnus von Knebel Doeberitz
HPV and Head and Neck Cancer by Maura Gillison
Questions and Answers Session - Immunotherapy and Antivirals
Perspectives for Cervical Cancer Control In Latin America by Rolando Herrero
RRP and L1 VLP Vaccines by Lutz Gissmann
Integrating HPV Vaccination, Screening and Treatment in Developed Countries by Marie-Helene Mayrand
Immune Response by Margaret Stanley
Association Of HPV DNA Presence With P16ink4a Expression in Oropharyngeal Cancers...
Measuring Vaccination Coverage by Susan Hariri
Looking to the Future - The Potential Impact of Molecular Screening by Nicolas Wentzensen
Questions & Answers Session 1 - Cervical Screening Guidelines: USA, Europe, Canada and Latin America
Screening Strategies 30 Year-Old Women and Older: US and European by Walter Kinney & Jack Cuzick
